Home > Insider Trading > Filing (0000899243-16-033679)

Filing Details

Accession Number:: 0000899243-16-033679
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-11-16 16:12:56
Reporting Period:: 2016-11-14

Filing Date:: 2016-11-16
Accepted Time:: 2016-11-16 16:12:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1629137	Global Blood Therapeutics Inc.	GBT	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1180428	J Mark Levin	29 Newbury Street, 3Rd Floor Boston MA 02116	No	No	Yes	No
1192595	I Robert Tepper	29 Newbury Street, 3Rd Floor Boston MA 02116	No	No	Yes	No
1192603	P Kevin Starr	29 Newbury Street, 3Rd Floor Boston MA 02116	No	No	Yes	No
1488495	Third Rock Ventures Ii, L.p.	C/O Third Rock Ventures, Llc 29 Newbury Street, 3Rd Floor Boston MA 02116	No	No	Yes	No
1569705	Third Rock Ventures Iii, L.p.	C/O Third Rock Ventures, Llc, 29 Newbury Street, 3Rd Floor Boston MA 02116	No	No	Yes	No
1614061	Third Rock Ventures Gp Ii, L.p.	29 Newbury Street, 3Rd Floor Boston MA 02116	No	No	Yes	No
1614073	Trv Gp Ii, Llc	29 Newbury Street, 3Rd Floor Boston MA 02116	No	No	Yes	No
1637299	Trv Gp Iii, Llc	29 Newbury Street, 3Rd Floor Boston MA 02116	No	No	Yes	No
1637300	Third Rock Ventures Gp Iii, L.p.	29 Newbury Street, 3Rd Floor Boston MA 02116	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-11-14	1,000,000	$19.36	9,475,191	No	4	S	Direct
Common Stock	Disposition	2016-11-14	1,000,000	$19.36	1,285,713	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership
Common Stock	108,957	Direct
Common Stock	108,955	Direct
Common Stock	108,956	Direct

Footnotes

These shares are directly held by Third Rock Ventures II, L.P. ("TRV II"). The general partner of TRV II is Third Rock Ventures GP II, L.P. ("TRV GP II"). The general partner of TRV GP II is TRV GP II, LLC ("TRV GP II LLC"). The individual managers of TRV GP II LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
These shares are directly held by Third Rock Ventures III, L.P. ("TRV III"). The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are Levin, Starr and Tepper. Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
Includes shares received by Levin, Starr and Tepper, as applicable, in a distributions-in-kind by TRV II on November 3, 2016, which distribution was made in accordance with the exemption afforded by Rule 16a-13 of the Securities Exchange Act of 1934, as amended.
These shares are directly held by Levin.
These shares are directly held by Starr.
These shares are directly held by Tepper.